Endra Life Sciences at Life

Endra Life Sciences. Ndra), a pioneer of thermo acoustic enhanced ultrasound (taeus®), and vgi health technology limited (nsx: Taeus is designed to work in concert with existing ultrasound systems.

The average endra life sciences stock forecast 2030 represents a 6.15% increase from the last price of $0.691999971866608. Ndra), a pioneer of thermo acoustic enhanced ultrasound (taeus®), has recently been issued u.s. Patent 11147067 (the ‘067 patent) titled, “method and system for monitoring tissue temperature” from the united states patent & trademark office.

ENDRA Life Sciences' NASH Test Device, TAEUS, At

(nasdaq:ndra) was the recipient of a significant decrease in short interest in the month of november. Endra has a global installed base of leading institutions using the. Taeus is designed to work in concert with existing ultrasound systems. Its photoacoustic solutions currently help global medical researchers screen and modify disease models with high image quality and volume scanning speed.